Ampio Pharma (AMPE) Reports Positive Data from Zertane Phase III in Patients with PE

Go back to Ampio Pharma (AMPE) Reports Positive Data from Zertane Phase III in Patients with PE
AMPIO PHARMACEUTICALS, Inc. (AMEX: AMPE) Delayed: 0.18 --0 (-0%)
Previous Close $0.18    52 Week High $4.32 
Open $0.18    52 Week Low $0.59 
Day High $0.18    P/E N/A 
Day Low $0.18    EPS $-0.63 
Volume 538